Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: rebecca who wrote (4761)	10/29/1997 11:48:00 PM
From: HeyRainier	Respond to of 9262

[ 3 Biotechs ] Nope, I did not see any ascending triangles among the group...at least they haven't formed any yet. Regards, Rainier

To: rebecca who wrote (4761)	10/31/1997 1:12:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9262

[ chat ] Rebecca: GLIA is my single largest holding. Too bad I've been awol, as I'd have gone gonzo when I saw it hit the list. More than just Adcon-L. See the thread. Recent renewal of the Alzheimer's deal with Janssen (JNJ), good preclinical data with a histamine3 receptor antagonist for attention deficit disorder, Adcon-T/N looking good, and more. IMO, the undervalued biotech. CALY..... strange company, worth watching. The founder was Director, Immunology at XOMA just before me. You learn a ton about a scientist from going through their lab notebooks. Guy is bright. Strange company, however. GNLB..... nah. Rick